Efficacy and Safety of Dexmedetomidine in the Analgesic Prophylaxis in Patients Undergoing Cardiovascular Surgery
-
- STATUS
- Recruiting
-
- days left to enroll
- 14
-
- participants needed
- 102
-
- sponsor
- University of Sao Paulo
Summary
Acute pain is one of the complications after cardiothoracic surgeries . It can delay patientsrecovery and may increase patientsmorbity and mortality. This study intends to evaluate Dexmedetomidine, a highly selective - 2 receptor agonist, that is currently applied safely and efficiently in intraoperative cardiac surgery. It has analgesic, sedative, anxiolytic and sympatholytic properties, without respiratory- depressant effect. The aim of this study is to investigate whether the intraoperative use of dexmedetomidine is better than the standard analgesia used in the intraoperative period to reduce pain and the consequences of it.
Description
This project is a prospective, double-blinded and randomized clinical trial. Eligible participants are assigned in a 1:1 ratio to either the intervention group (Group Dexmedetomidine) or control group (Group Saline 0,9%), after written informed consent to be obtained. The patients will undergo elective cardiac surgery, with extracorporeal circulation.
In the operating room, patients will be monitored for pulse oximetry, invasive blood pressure, electrocardiograms, capnography, central venous pressure and nasopharyngeal temperature probe. Induction of anesthesia is performed with intravenous midazolam, fentanyl, etomidate and neuromuscular blocking agent. Anesthesia is maintained with sevoflurane. Dexmedetomidine, at the rate of 0,3g/ kg/h, or placebo will be infused from the initiation of the anesthesia up to the end of the procedure, except during the cardiopulmonary by-pass. Placebo is a 0,9% saline. The follow up of the assessment of the groups will extend to the postoperative ICU, where data will be collected, during the first 24 hours after surgery.
Details
| Condition | Cardiac Disease, ache, cardiac disorders, Heart Valve Disease, Coronary heart disease, Acute Pain Service, Cardiac Ischemia, Coronary Artery Disease, heart diseases, heart disorder, Post-Surgical Pain, Myocardial Ischemia, cardiac disorder, Heart Disease, cardiac diseases, VALVULAR HEART DISEASE, Heart disease, Pain (Pediatric), Pain |
|---|---|
| Treatment | Dexmedetomidine, 0,9% saline |
| Clinical Study Identifier | NCT05079672 |
| Sponsor | University of Sao Paulo |
| Last Modified on | 28 October 2021 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer